Company Profile
Noxilizer, Inc. Basic Information, Manufacturing Base, Sales Area, and Competitors
|
Sr. No. |
Item |
Description |
|
1 |
Company Name |
Noxilizer, Inc. |
|
2 |
Website |
noxilizer.com/ |
|
3 |
Established Date |
2004 |
|
4 |
Headquartered |
United States |
|
5 |
Market Position/ History |
Founded in 2004, Noxilizer focused on developing ultra-low temperature nitrogen dioxide (NO?) sterilization technology. The company quickly established itself as a leader in providing efficient and safe alternatives to traditional sterilization methods, serving the pharmaceutical, biotech, and medical device industries. Initially offering contract sterilization services, Noxilizer expanded its capabilities to include regulatory consulting, product design, and material selection for sterilization. Over time, it has become a trusted partner for global companies, assisting them in meeting their sterilization needs while preserving product integrity. Noxilizer continues to drive innovation with advanced sterilization solutions. |
|
6 |
Sales Area |
Worldwide |
|
7 |
Manufacturing Location |
United States |
|
8 |
Competitors |
C.B.M. S.r.l. Medical Equipement Fortive Corporation Cardinal Health Inc |
|
9 |
CEO |
Christopher A. Thatcher |
|
10 |
Ownership Type |
Private |
|
11 |
Contact Information |
1334 Ashton Road, Suite E Hanover, MD 21076 Tel: (443) 842-4400 |
Business Segment or Overview of Noxilizer, Inc
Noxilizer is a rapidly growing medical technology company that specializes in ultra-low temperature nitrogen dioxide (NO?) sterilization, providing a safer and more efficient alternative to traditional sterilization methods. Focused on the pharmaceutical, biotech, and medical device industries, Noxilizer offers a wide range of services, including sterilization testing, regulatory consulting, device and material design consulting, feasibility studies, and contract sterilization.
The company's RTS sterilizers are available in various chamber sizes, ranging from 400 liters to 16,000 liters, to meet the diverse needs of its customers. Noxilizer’s approach minimizes sterilization-related risks while ensuring the integrity and safety of drugs. Their nitrogen dioxide (NO?) sterilization process eliminates harmful residuals and offers a cost-effective, ultra-low temperature solution, making it a preferred choice for products such as pre-filled syringes and drug delivery systems.
Medical Devices Sterilizaton Types Specification
|
Product & Services |
Product Description |
|
UltraNox Sterilizer |
Noxilizer provides sterilizers with chamber sizes ranging from 400 liters to 16,000 liters. They collaborate with customers to determine the most suitable unit size based on packaging dimensions and both current and future annual volume requirements. Pre-filled syringes, drug-delivery products used in sterile environments, and drugs with specific indications are among the products that benefit the most from NO? sterilization. Other features of UltraNox Sterilizers include: Single and double door models available Typical cycle time 6-12 hours, including aeration, leading to increased efficiency Minimal vacuum cycle available for pressure-sensitive products Scrubber captures NO2 gas after cycle is complete, protects the environment Sensors throughout the sterilizer to ensure safety Applications Prefilled Syringes and Combination Products Sensors Orthopedic Implants |
Recent Developments
|
Year |
Latest News |
|
April, 2024 |
Noxilizer expands NO2 contract sterilization in the United States Noxilizer has announced the availability of NO? contract sterilization at its Hanover, MD headquarters in the United States. This facility is strategically located near the Baltimore Washington International Airport and close to global pharmaceutical companies, as well as leading contract manufacturing organizations (CMOs). NO? sterilization has become the preferred method for sterilizing pre-filled syringes and drug-device combination products. Commercialized by Noxilizer in 2012, NO? sterilization offers several key advantages: ultra-low temperatures (10°-30°C), minimal pressure requirements, little to no residuals, and quick cycle times (6–12 hours, including aeration). This method of sterilization opens new possibilities for innovation and has proven to be especially effective in sterilizing pre-filled syringes, drug-device combination products, and custom implants. |
X
Profile Details
-
Author Anushka Gore
-
Published 10 Nov 2025
-
Last Updated 10 Nov 2025
-
Reading Time~5 minutes
-
CoverageSWOT, Financials, Key Employees, History
Table of Contents
-
- 1.1 About Noxilizer Inc
- 1.2 Key Facts
- 1.3 Key Employees
- 1.3.1 Key Employee Biographies
- 1.4 History
- 1.5 Locations & Subsidiaries
- 1.5.1 Head Office
- 1.5.2 Other Locations & Subsidiaries
-
- 2.1 Company Overview
- 2.2 Business Segments
- 2.3 R&D Overview
- 2.4 Brands
- 2.5 Key Company Statistics
- 2.6 Key Financials (2015–2019)
- 2.7 Share Holder Analysis
- 2.8 Regional Presence
- 2.9 Services Offered
-
- 3.1 Strengths
- 3.2 Weaknesses
- 3.3 Opportunities
- 3.4 Threats
- 3.5 Key Competitors
-
- 4.1 Company Metrics
- 4.2 Key Investors
- 4.3 Recent Funding & Valuation
- 4.4 Historical Funding & Valuation
-
- 5.1 Acquisitions
- 5.2 Partnerships
-
- 6.1 Latest News & Announcements
- 6.2 Strategic Initiatives
-
- 7.1 Summary of Findings
- 7.2 Strategic Recommendations
Get a Custom Profile
Need a tailored company profile or competitive intelligence report? Our analysts are ready to help.
Contact Our ExpertsMore Profiles
Explore all published company profiles across 30+ industry verticals.
View All Profiles